Comparative Effectiveness of Treatments for Relapsed or Refractory Mantle Cell Lymphoma (R/R MCL), Using Matching Adjusted Indirect Comparison
Value Health
.
2014 Nov;17(7):A614-5.
doi: 10.1016/j.jval.2014.08.2163.
Epub 2014 Oct 26.
Authors
V Tongbram
1
,
N Sengupta
2
,
M Gaudig
3
,
M Sidhu
1
,
A Exuzides
4
,
C Colby
4
,
S V Sanden
5
,
A McGovern
1
Affiliations
1
ICON Plc, Morristown, NJ, USA.
2
Janssen Pharmaceuticals, Inc, Raritan, NJ, USA.
3
Janssen Pharmaceuticals, Inc, Neuss, Germany.
4
ICON plc, San Francisco, CA, USA.
5
Janssen Pharmaceuticals, Inc., Beerse, Belgium.
PMID:
27202151
DOI:
10.1016/j.jval.2014.08.2163
No abstract available